organization · Reporting owner
Proem SPAC Partners I LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Proem Acquisition Corp. IPAAC · Entity 6400 | 10% owner | February 13, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Proem Acquisition Corp. I
Report date February 13, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 4,625,833 |
Reported balance
After 2026-02-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-13 · Purchase · Acquired 292,500 · Balance 4,625,833 F2: Reflects the 292,500 private units owned by the Sponsor. Each private unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased pursuant to a Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Sponsor and the Issuer, at $10.00 per unit for an aggregate purchase price of $2,925,000. F1: Proem SPAC Partners I LLC, the Issuer's sponsor (the "Sponsor"), purchased 4,983,333 ordinary shares for $25,000. Among which, 650,000 ordinary shares are subject to forfeited depending on the extent to which the underwriters' over-allotment option is exercised. |
| Warrants to purchase Ordinary SharesSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | 146,573 |
Reported balance
After 2026-02-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-13 · Purchase · Acquired 146,250 · Balance 146,573 F2: Reflects the 292,500 private units owned by the Sponsor. Each private unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased pursuant to a Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Sponsor and the Issuer, at $10.00 per unit for an aggregate purchase price of $2,925,000. F3: The warrants included in the private units will become exercisable on the later of (i) the completion of the Issuer's initial business combination, or (ii) February 11, 2027 (12 months after the Issuer's registration statement has been declared effective by the Securities and Exchange Commission), and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. |
Filing footnotes · ownership attribution and instrument terms
F1: Proem SPAC Partners I LLC, the Issuer's sponsor (the "Sponsor"), purchased 4,983,333 ordinary shares for $25,000. Among which, 650,000 ordinary shares are subject to forfeited depending on the extent to which the underwriters' over-allotment option is exercised.
F2: Reflects the 292,500 private units owned by the Sponsor. Each private unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased pursuant to a Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Sponsor and the Issuer, at $10.00 per unit for an aggregate purchase price of $2,925,000.
F3: The warrants included in the private units will become exercisable on the later of (i) the completion of the Issuer's initial business combination, or (ii) February 11, 2027 (12 months after the Issuer's registration statement has been declared effective by the Securities and Exchange Commission), and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2026 Filed Mar 4, 2026 23:44 UTC | Proem Acquisition Corp. I PAAC · Entity 6400 | PurchaseWarrants to purchase Ordinary Shares · Derivative | 146,250 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001213900-26-023768 · ownership.xml · derivative · entry 2 Proem SPAC Partners I LLC · CIK 0002112560 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,573 Underlying: Ordinary Shares · 146,250 shares Expires not disclosed F2 · price: Reflects the 292,500 private units owned by the Sponsor. Each private unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased pursuant to a Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Sponsor and the Issuer, at $10.00 per unit for an aggregate purchase price of $2,925,000. F3 · derivative.exercise_date: The warrants included in the private units will become exercisable on the later of (i) the completion of the Issuer's initial business combination, or (ii) February 11, 2027 (12 months after the Issuer's registration statement has been declared effective by the Securities and Exchange Commission), and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. F3 · derivative.expiration_date: The warrants included in the private units will become exercisable on the later of (i) the completion of the Issuer's initial business combination, or (ii) February 11, 2027 (12 months after the Issuer's registration statement has been declared effective by the Securities and Exchange Commission), and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. Read SEC document |
| February 13, 2026 Filed Mar 4, 2026 23:44 UTC | Proem Acquisition Corp. I PAAC · Entity 6400 | PurchaseOrdinary Shares | 292,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-26-023768 · ownership.xml · nonDerivative · entry 1 Proem SPAC Partners I LLC · CIK 0002112560 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,625,833 F2 · price: Reflects the 292,500 private units owned by the Sponsor. Each private unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased pursuant to a Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Sponsor and the Issuer, at $10.00 per unit for an aggregate purchase price of $2,925,000. F1 · balance_after: Proem SPAC Partners I LLC, the Issuer's sponsor (the "Sponsor"), purchased 4,983,333 ordinary shares for $25,000. Among which, 650,000 ordinary shares are subject to forfeited depending on the extent to which the underwriters' over-allotment option is exercised. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.